Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.

NCT01703728 · clinicaltrials.gov ↗

COMPLETED

Status

455

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Hyperstimulation Syndrome (OHSS)

Interventions

OTHER: Highly purified menotropin (HP- hMG) treatment

Sponsor

Ferring Pharmaceuticals